Navigation Links
TyRx Pharma, Inc. Announces Presentation of Results to Benefit Women with Breast Implants (In-Vivo Efficacy Study Regarding AIGISRx DEB) at the Plastic Surgery 2007 Meeting on October, 28 2007 in Baltimore, MD
Date:10/24/2007

AIGISRx DEB is designed to reduce the severity of capsular contracture following breast implantation via a reduction in bacterial colonization and

capsule formation

MONMOUTH JUNCTION, N.J., Oct. 24 /PRNewswire/ -- TyRx Pharma, Inc., a leader in the commercialization of implantable medical-pharmaceutical devices, announced today acceptance for presentation during the Plastic Surgery 2007 Society meeting, (October 26-31, 2007, Baltimore, MD) the paper entitled, "Prevention of Experimental Capsular Contracture in Breast Implants by an Antimicrobial-Impregnated Biodegradable Wrap". These study results demonstrate the potential of the TyRx AIGISRx DEB technology to address a significant unmet clinical need for women who have had breast augmentation.

William P. Adams, Jr., MD, Principal Investigator, Plastic Surgeon, Dallas, an international expert in breast augmentation, breast implants and capsular contracture, will present the paper during the "Hot Topics in Plastic Surgery" session, October 27 between 12-4PM. Dr. Adams was Chief of Plastic Surgery, Parkland Health and Hospital System, Dallas, and formerly Associate Professor, Department of Plastic Surgery, UT Southwestern Medical. Dr. Adams graduated B.A. Princeton University, Cum Laude, Biology and received his medical training at Vanderbilt School of Medicine. TyRx Pharma sponsored the study.

Regarding the results of the In-Vivo Efficacy Study of AIGISRx DEB, Dr. Adams remarked, "We have seen great success minimizing capsular contracture with standardized techniques and appropriate breast pocket irrigations. The study results demonstrate that this device provides superior antimicrobial protection compared to current irrigation methods with less inflammation and capsule formation. It appears that this device may greatly benefit all patients with breast implants."

Capsular Contracture, a deformation of the breast implant due to formation of fibrotic tissue
'/>"/>

SOURCE TyRx Pharma, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Orchid to Buy out Bexel Pharma, US
2. PM announces a new health care order for India
3. Ramdoss Announces Introduction of RCH-II
4. Britain Announces Third Transfusion Related Mad Cow Case
5. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
6. Tibet Announces the Dalai Lama’s Tour of South Americ
7. NHS announces further Cost cutting Measures
8. Indian PM Announces Of Setting Up India Study Center At Tashkent
9. PowderMed Announces Needle-Less Flu Vaccine
10. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
11. Australian Government Announces Survey To Tackle Childhood Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...N, Dec. 2 In the wake o...institutions - highlighting a pattern of abuse and...s - a national coalition of such individuals is ca... nation,s top mental health officials to institute...al health treatment system. These would include ra...
(Date:12/2/2008)...ediatric dermatologist explains prevalence of wint...008/2009 diaper rash season , COLLEGEVILLE, Pa...he millions of diaper-clad babies, the winter mont...ed button noses, and not-so-cute and oh-so-painful...baby,s skin health until sunscreen season comes ar...
(Date:12/2/2008)... SANTA MONICA, Calif., Dec. 2 /PRNewswire-USNews...og sent a letter today to President-elect Obama ur...alth care affordable and available by allowing any... group warned Obama that a proposal pushed by heal... buy private health insurance policies "amounts on...
(Date:12/2/2008)...edical Journal study finds natural, less expensive...rome Sufferers , , PRINCETON, N.J., Dec. 2 ... gatherings, the holiday season is, for most, anti... million Americans who suffer from Irritable Bowel...the fear of sudden embarrassing and debilitating g...
Breaking Medicine News(10 mins):Health News:Tragedies Underscore Crisis in U.S. Public Mental Health System: National Advocacy Organization Demands Reforms 2Health News:Tragedies Underscore Crisis in U.S. Public Mental Health System: National Advocacy Organization Demands Reforms 3Health News:Photos: Heads Up, Parents: Get to the Bottom of Winter Diaper Rash 2Health News:Photos: Heads Up, Parents: Get to the Bottom of Winter Diaper Rash 3Health News:Photos: Heads Up, Parents: Get to the Bottom of Winter Diaper Rash 4Health News:Consumer Watchdog to Obama: Open Medicare to All Americans 2Health News:Consumer Watchdog to Obama: Open Medicare to All Americans 3Health News:Holiday Season Brings New Hope to Millions Who Suffer from Common Chronic Health Disorder 2
...ng to the researcher Steve Allen of Stanford Unive...k holes in the space are the most fuel-efficient e...sed in a car it will go about a billion miles (1.6...itres) of gas. Huge bubbles in the hot cosmic gas...
...r adults Age-related Macular Degeneration (AMD) is...erson's risk to develop the disease may partly dep...tes consumed must be of primary concern rather th...Allen Taylor, PhD, director of the Laboratory for ...
...in called calpain can play a key role in regulatin.... Proof has been raised by these scientists //that...er cells but can be directed to prevent cell deat...ase of Alzheimer’s or Parkinson’s. Dr. Greer is a ...
... policy of free personal care for the elderly was ...hich seemed to guarantee the dignity and security ...filled with controversies over serious lack of fun...ng that they have already run out of money to prov...
Other Medicine News:Health News:Quality Of Dietary Carbohydrates May Determine Quality Of Eye Sight 2Health News:Quality Of Dietary Carbohydrates May Determine Quality Of Eye Sight 3Health News:Protein’s role in regulating cell death sets direction for Alzheimer’s, Parkinson’s and cancer resea 2
(Date:12/2/2008)...e/ -- Horizon Therapeutics, Inc., a,privately hel...two pivotal,Phase 3 trials evaluating its lead in... primary endpoints. HZT-501, a novel, proprietary ...en and famotidine, demonstrated a,statistically s...idal,anti-inflammatory drug (NSAID)-induced upper...
(Date:12/1/2008)...-- TargeGen has announced that an oral,presentati...-based clinical,trial of TG101348 in myeloprolife... 2008 American Society of Hematology (ASH) Meeting...llows:, Title: A Phase I Study ... JAK2-Selective Inhibitor, in Patients w...
(Date:12/1/2008)...est policy , , ROCHESTER, Minn., Dec. 1 /P...nic finds the use of the drug therapy etanercept i...te inflammation of the liver caused by excessive c...e published in the December issue of Gastroentero... VIDEO ALERT: Additional audio and video resourc...
(Date:12/1/2008)...irstCall/ -- Vical Incorporated (Nasdaq: VICL ) ...stone payment from Merck & Co., Inc. based on ...rial of an investigational plasmid DNA (pDNA) canc...l,s DNA gene delivery technology and encodes human...s the subject of separate license agreement. , ...
Breaking Medicine Technology:Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2A new explanation for evolutionary changes in genetic sex determination systems 894 1A new explanation for evolutionary changes in genetic sex determination systems 894 2Morrison Takes Aim at Underage Drinking in New Radio Campaign 4166 1Morrison Takes Aim at Underage Drinking in New Radio Campaign 4166 2Spectranetics to Hold 2007 Third Quarter Financial Results Conference Call on October 31 4162 1Spectranetics to Hold 2007 Third Quarter Financial Results Conference Call on October 31 4162 2Perrigo Company Will Release First Quarter Fiscal 2008 Results on November 1 2007 4158 1
... with tumor lysate,triggers robust antigen-specifi...Japan, June 22, 2007,/PRNewswire/ -- MaxCyte, Inc....sentation at the 13th Annual Meeting of the,Intern...is being,held June 24-27, 2007 in Sydney, Australi...of mature dendritic,cells with tumor lysate trigge...
...Newswire/ -- Speaker,Nancy Pelosi issued the follo...,s veto of the stem cell bill: , "Once again, the ...ple, of leading medical researchers, and of a bipa...ys ,no, to the hopes of,million of families across...al of lifesaving treatment,and enjoys the overwhel...
Other Medicine Technology:MaxCyte and Medinet to Present at the 13th Annual Meeting of the,International Society for Cellular Therapy (ISCT) in Sydney,Australia 2MaxCyte and Medinet to Present at the 13th Annual Meeting of the,International Society for Cellular Therapy (ISCT) in Sydney,Australia 3
Medium Surgical Clips. 6 clips per cartridge. Box of 30 cartridges with a total of 180 titanium clips per box. For secure vasal and other occlusion.
Thermal Cautery, Reusable Base Unit. Burns at approximately 1200C (2200 F), non-sterile base unit with 1 non-sterile tip, 1 set single-use batteries. The two (2) AA batteries are replaceable (alkalin
Platinum General Purpose Cautery Electrodes , ,A - Loop Tip, ,Fully autoclavable. Tips typically last for 50 to 100 or more procedures, depending on burn time.
No Scalpel Vasectomy Ring Clamp, 5 1/2" (14cm), gold finger rings
Medicine Products: